Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Mallinckrodt
Argus Health
Baxter
McKesson
Queensland Health

Generated: September 21, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Clinical Trials for sulfur hexafluoride lipid-type a microspheres

Trial ID Title Status Sponsor Phase Summary
NCT03040323 Prospective Analysis of Value of Contrast-enhanced Sonography During Biopsies of Focal Liver Masses Recruiting Indiana University Phase 4 The investigators plan to compare complication and success rates between two methods of ultrasound guidance for biopsy of liver lesions, contrast-enhanced and the current protocol without contrast.
NCT03300401 Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization Not yet recruiting National Cancer Institute (NCI) N/A This pilot clinical trial studies how well contrast-enhanced ultrasound in diagnosing patients with liver cancer who are undergoing Yttrium-90 radioembolization. Contrast-enhanced ultrasound may provide detailed imaging of the tumor arteries after the injection of a contrast-agent consisting of microbubbles, and may predict how much Yttrium-90 will deposit in the tumor.
NCT03300401 Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization Not yet recruiting University of Southern California N/A This pilot clinical trial studies how well contrast-enhanced ultrasound in diagnosing patients with liver cancer who are undergoing Yttrium-90 radioembolization. Contrast-enhanced ultrasound may provide detailed imaging of the tumor arteries after the injection of a contrast-agent consisting of microbubbles, and may predict how much Yttrium-90 will deposit in the tumor.
>Trial ID >Title >Status >Phase >Summary

Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for sulfur hexafluoride lipid-type a microspheres

Condition Name

Condition Name for sulfur hexafluoride lipid-type a microspheres
Intervention Trials
Hepatocellular Carcinoma 2
Diseases of Liver 1
Acute Appendicitis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for sulfur hexafluoride lipid-type a microspheres
Intervention Trials
Carcinoma, Hepatocellular 2
Carcinoma 2
Liver Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for sulfur hexafluoride lipid-type a microspheres

Trials by Country

Trials by Country for sulfur hexafluoride lipid-type a microspheres
Location Trials
United States 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for sulfur hexafluoride lipid-type a microspheres
Location Trials
Missouri 1
Texas 1
Indiana 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for sulfur hexafluoride lipid-type a microspheres

Clinical Trial Phase

Clinical Trial Phase for sulfur hexafluoride lipid-type a microspheres
Clinical Trial Phase Trials
Phase 4 1
Phase 2 1
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for sulfur hexafluoride lipid-type a microspheres
Clinical Trial Phase Trials
Recruiting 3
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for sulfur hexafluoride lipid-type a microspheres

Sponsor Name

Sponsor Name for sulfur hexafluoride lipid-type a microspheres
Sponsor Trials
National Cancer Institute (NCI) 2
University of Southern California 1
Indiana University 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for sulfur hexafluoride lipid-type a microspheres
Sponsor Trials
Other 4
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Medtronic
Moodys
Covington
Daiichi Sankyo
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.